Resources
Menu
Close
Resources
Contact us
Oral solid dose
Sterile injectables
Antibody-drug conjugates
Tech transfer
OSD manufacturing
SI manufacturing
ADC manufacturing
Careers
Leadership team
Sustainability
IP protection
Expert insights
CMO solutions for complex OSD commercialization: How Pfizer CentreOne can help
To meet the demands of the oral solid dosage (OSD) market, new techniques and technologies have emerged. While these have allowed developers to break new ground in harnessing innovative active pharmaceutical ingredients (APIs), the production of OSD therapeutics has become more and more complicated.
At Pfizer CentreOne, we help make the complex simple.
We leverage our state-of-the-art facilities and decades of experience to deliver high-quality OSD products — including highly potent, cytotoxic and low bioavailability drugs — to support even the most challenging OSD products. This application note explores the OSD production and manufacturing methods we use to help achieve your goals.
Please submit the form below to download your resource
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please click below.
By clicking here and clicking “Submit” below, I consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Pfizer CentreOne believes may be of value to me, relevant to my work and tailored to my professional profile and interests. This may include promotional information on products, services and events provided or organized by Pfizer CentreOne.
By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Pfizer’s processing of your personal data, including its transfer internationally and to third parties, in accordance with the Pfizer Privacy Policy and Pfizer website terms of use.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Submit
Success
Thank you, your submission has been received!
Success
Thank you, your submission has been received!
Latest marketing updates
Let’s stay in touch
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
BY TICKING THE BOX AND CLICKING “LET’S COLLABORATE” BELOW, I CONSENT TO RECEIVING THOUGHT LEADERSHIP, INDUSTRY NEWS, AND INVITATIONS BY EMAIL OR OTHER ELECTRONIC MEANS, WHICH PFIZER CENTREONE BELIEVES MAY BE OF VALUE TO ME, RELEVANT TO MY WORK AND TAILORED TO MY PROFESSIONAL PROFILE AND INTERESTS. THIS MAY INCLUDE PROMOTIONAL INFORMATION ON PRODUCTS, SERVICES AND EVENTS PROVIDED OR ORGANIZED BY PFIZER CENTREONE.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Let's Collaborate
A CMO for therapies that define legacies
Follow us
Latest marketing updates
Sign up
© 2025 Pfizer Inc. All rights reserved. Pfizer CentreOne is a registered trademark of Pfizer Inc. Privacy Policy | Terms of Use